Matrix metalloproteinases in rectal mucosa, tumour and plasma: Response after preoperative irradiation

International Journal of Colorectal Disease

Volumn 22, Issue 6, 2007, Pages 667-674

  Angenete, Eva ^a   Langenskiöd, Marcus ^a   Falk, Peter ^a   Ivarsson, Marie Louise ^b  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b Kungsbacka University Hospital   (Sweden)

Author keywords

Distant metastases; Extracellular matrix; Irradiation; Matrix metalloproteinase; Rectal cancer

Indexed keywords

ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; LOW MOLECULAR WEIGHT HEPARIN; MATRIX METALLOPROTEINASE;

ADULT; AGED; ANASTOMOSIS DEHISCENCE; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METASTASIS; METASTASIS POTENTIAL; MORBIDITY; POSTOPERATIVE PERIOD; POSTOPERATIVE THROMBOSIS; PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; RADIATION RESPONSE; RECTUM BIOPSY; RECTUM CANCER; RECTUM FISTULA; RECTUM MUCOSA; RECTUM SURGERY; SMALL INTESTINE OBSTRUCTION; STATISTICAL SIGNIFICANCE; SURGICAL INFECTION; TREATMENT OUTCOME; WOUND HEALING;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FISTULA; HUMANS; MALE; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; MIDDLE AGED; MUCOUS MEMBRANE; NEOPLASM STAGING; PREOPERATIVE CARE; RECTAL NEOPLASMS; RECTUM; TREATMENT OUTCOME;

EID: 34547102747     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-006-0225-3     Document Type: Article

References (39)

1. MacFarlane JK, Ryall RD, Heald RJ (1993) Mesorectal excision for rectal cancer. Lancet 341:457-460
2. Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T, Rutten HJ, Pahlman L, Glimelius B, van Krieken JH, Leer JW, van de Velde CJ (2001) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345:638-646
3. Glimelius B, Gronberg H, Jarhult J, Wallgren A, Cavallin-Stahl E (2003) A systematic overview of radiation therapy effects in rectal cancer. Acta Oncol 42:476-492
4. [No Authors Listed] (1997) Swedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med 336:980-987
5. Folkesson J, Birgisson H, Pahlman L, Cedermark B, Glimelius B, Gunnarsson U (2005) Swedish Rectal Cancer Trial: Long lasting benefits from radiotherapy on survival and local recurrence rate. J Clin Oncol 23:5644-5650
6. Dahlberg M, Glimelius B, Graf W, Pahlman L (1998) Preoperative irradiation affects functional results after surgery for rectal cancer: results from a randomized study. Dis Colon Rectum 41:543-549; discussion 549-551
7. Dehni N, McNamara DA, Schlegel RD, Guiguet M, Tiret E, Parc R (2002) Clinical effects of preoperative radiation therapy on anorectal function after proctectomy and colonic J-pouch-anal anastomosis. Dis Colon Rectum 45:1635-1640
8. Holm T, Singnomklao T, Rutqvist LE, Cedermark B (1996) Adjuvant preoperative radiotherapy in patients with rectal carcinoma. Adverse effects during long term follow-up of two randomized trials. Cancer 78:968-976
9. Miller G, Boman J, Shrier I, Gordon PH (2000) Etiology of small bowel obstruction. Am J Surg 180:33-36
10. Ooi BS, Tjandra JJ, Green MD (1999) Morbidities of adjuvant chemotherapy and radiotherapy for resectable rectal cancer: An overview. Dis Colon Rectum 42:403-418
11. Birgisson H, Pahlman L, Gunnarsson U, Glimelius B (2005) Adverse effects of preoperative radiation therapy for rectal cancer: Long-term follow-up of the Swedish rectal cancer trial. J Clin Oncol 23:8697-8705
12. Cedermark B, Theve NO, Rieger A, Wahren B, Glas JE, Rubio C, Ost A, Brostrom L, Ekelund G, Forsgren L et al (1985) Preoperative short-term radiotherapy in rectal carcinoma. A preliminary report of a prospective randomized study. Cancer 55:1182-1185
13. Cedermark B, Johansson H, Rutqvist LE, Wilking N (1995) The Stockholm I trial of preoperative short term radiotherapy in operable rectal carcinoma. A prospective randomized trial. Stockholm Colorectal Cancer Study Group. Cancer 75:2269-2275
14. Birgisson H, Pahlman L, Gunnarsson U, Glimelius B (2005) Occurrence of second cancers in patients treated with radiotherapy for rectal cancer. J Clin Oncol 23:6126-6131
15. Rodemann HP, Bamberg M (1995) Cellular basis of radiation-induced fibrosis. Radiother Oncol 35:83-90
16. Coia LR, Myerson RJ, Tepper JE (1995) Late effects of radiation therapy on the gastrointestinal tract. Int J Radiat Oncol Biol Phys 31:1213-1236
17. Baker EA, Leaper DJ (2002) Measuring gelatinase activity in colorectal cancer. Eur J Surg Oncol 28:24-29
18. Langenskiöld M, Holmdahl L, Falk P, Ivarsson ML (2004) Increased plasma MMP-2 protein expression in lymph node positive patients with colorectal cancer. Int J Colorectal Dis 20:245-252
19. Kumar A, Collins HM, Scholefield JH, Watson SA (2000) Increased type-IV collagenase (MMP-2 and MMP-9) activity following preoperative radiotherapy in rectal cancer. Br J Cancer 82:960-965
20. Hovdenak N, Wang J, Sung CC, Kelly T, Fajardo LF, Hauer-Jensen M (2002) Clinical significance of increased gelatinolytic activity in the rectal mucosa during external beam radiation therapy of prostate cancer. Int J Radiat Oncol Biol Phys 53:919-927
21. Strup-Perrot C, Vozenin-Brotons MC, Vandamme M, Benderitter M, Mathe D (2006) Expression and activation of MMP-2, -3, -9, -14 are induced in rat colon after abdominal X-irradiation. Scand J Gastroenterol 41, 60-70.
22. Ivarsson ML, Bergstrom M, Eriksson E, Risberg B, Holmdahl L (1998) Tissue markers as predictors of postoperative adhesions. Br J Surg 85:1549-1554
23. Falk P, Ivarsson ML (2003) Examination gloves affect secretion of matrix metalloproteinases and their inhibitors from human abdominal skin fibroblasts. Wound Repair Regen 11:230-234
24. Lowry O, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193:265-275
25. Mook OR, Frederiks WM, Van Noorden CJ (2004) The role of gelatinases in colorectal cancer progression and metastasis. Biochim Biophys Acta 1705:69-89
26. Tutton MG, George ML, Eccles SA, Burton S, Swift RI, Abulafi AM (2003) Use of plasma MMP-2 and MMP-9 levels as a surrogate for tumour expression in colorectal cancer patients. Int J Cancer 107:541-550
27. Oberg A, Hoyhtya M, Tavelin B, Stenling R, Lindmark G (2000) Limited value of preoperative serum analyses of matrix metalloproteinases (MMP-2, MMP-9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, TIMP-2) in colorectal cancer. Anticancer Res 20:1085-1091
28. Kirkegaard T, Hansen A, Bruun E, Brynskov J (2004) Expression and localisation of matrix metalloproteinases and their natural inhibitors in fistulae of patients with Crohn's disease. Gut 53:701-709
29. Stumpf M, Klinge U, Wilms A, Zabrocki R, Rosch R, Junge K, Krones C, Schumpelick V (2005) Changes of the extracellular matrix as a risk factor for anastomotic leakage after large bowel surgery. Surgery 137:229-234
30. Stumpf M, Cao W, Klinge U, Klosterhalfen B, Kasperk R, Schumpelick V (2002) Collagen distribution and expression of matrix metalloproteinases 1 and 13 in patients with anastomotic leakage after large-bowel surgery. Langenbecks Arch Surg 386:502-506
31. Syk I, Agren MS, Adawi D, Jeppsson B (2001) Inhibition of matrix metalloproteinases enhances breaking strength of colonic anastomoses in an experimental model. Br J Surg 88:228-234
32. Matthiessen P, Hallbook O, Andersson M, Rutegard J, Sjodahl R (2004) Risk factors for anastomotic leakage after anterior resection of the rectum. Colorectal Dis 6:462-469
33. Lele S, Radstone D, Eremin J, Kendal R, Hosie KB (2000) Prospective audit following the introduction of short-course preoperative radiotherapy for rectal cancer. Br J Surg 87:97-99
34. Roeb E, Dietrich CG, Winograd R, Arndt M, Breuer B, Fass J, Schumpelick V, Matern S (2001) Activity and cellular origin of gelatinases in patients with colon and rectal carcinoma differential activity of matrix metalloproteinase-9. Cancer 92:2680-2691
35. Roeb E, Arndt M, Jansen B, Schumpelick V, Matern S (2004) Simultaneous determination of matrix metalloproteinase (MMP)-7, MMP-1, -3, and -13 gene expression by multiplex PCR in colorectal carcinomas. Int J Colorectal Dis 19:518-524
36. Murray GI, Duncan ME, O'Neil P, Melvin WT, Fothergill JE (1996) Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer. Nat Med 2:461-462
37. Di Colandrea T, Wang L, Wille J, D'Armiento J, Chada KK (1998) Epidermal expression of collagenase delays wound-healing in transgenic mice. J Invest Dermatol 111:1029-1033
38. Susskind H, Hymowitz MH, Lau YH, Atkins HL, Hurewitz AN, Valentine ES, Meek AG, Zucker S (2003) Increased plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in lung and breast cancer are altered during chest radiotherapy. Int J Radiat Oncol Biol Phys 56:1161-1169
39. Edna TH, Bjerkeset T (1998) Small bowel obstruction in patients previously operated on for colorectal cancer. Eur J Surg 164:587-592